Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Product Theater Reporter

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

Publications
Sections
Product Theater Reporter
Product Theater Reporter

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

Publications
Publications
Article Type
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Sections
Disallow All Ads

Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Product Theater Reporter

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Click here to open the supplement

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

Publications
Sections
Product Theater Reporter
Product Theater Reporter

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Click here to open the supplement

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

December 2014

A supplement to Family Practice News® and Internal Medicine News®. This supplement is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Click here to open the supplement

Topics

 

  • Pain in the United States
  • Critical Comorbid Illnesses
  • Impact of Pain on Comorbidities and Patient Outcomes
  • Pain Management for Patients Taking Concomitant Medications
  • Benefits of OTC Analgesics
  • Risks of OTC Analgesics
  • A Nursing Perspective
  • Not All Analgesics Are Appropriate for Every Patient
  • Patients’ Safe Use of OTC Analgesics
  • Conclusions

 

Faculty

Chairman
Charles P. Vega, Jr, MD, FAAFP
Clinical Professor, Department of Family Medicine
Director, Patient-Centered Advanced Clinical Education
Director, Program in Medical Education for the Latino Community
University of California, Irvine, School of Medicine
Irvine, California

Faculty
Christopher M. Chappel, MD
Medical Director
Chappel Health and Wellness
Kissimmee, Florida

Brett Badgley Snodgrass, MSN, APRN, FNP-BC
Family Nurse Practitioner
Saint Francis Hospital–Bartlett Interventional Pain Management Clinic
Chief Executive Officer and President
BBS Consultants, Inc.
Bartlett, Tennessee
 

 

 

Copyright © 2014 by Frontline Medical Communications Inc.

Publications
Publications
Article Type
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Display Headline
Current Thinking in OTC Analgesia: Patient Considerations and Practical Insights
Sections
Disallow All Ads
Alternative CME

Understanding U.S. Cardiologists’ Perspectives on Non-Valvular Atrial Fibrillation (NVAF)

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Understanding U.S. Cardiologists’ Perspectives on Non-Valvular Atrial Fibrillation (NVAF)

A supplement to Cardiology News. This supplement was sponsored by Daiichi Sankyo Inc.

The prevalence of atrial fibrillation (AF) is growing worldwide, and it’s vital for the medical community to better understand the disease and those affected. Daiichi Sankyo sponsored a global survey that was conducted in partnership with the Heart Rhythm Society. The global survey of cardiologists illuminates several important considerations regarding the care and management of patients with non-valvular atrial fibrillation (NVAF).

Faculty:
Hugh Calkins, MD, FHRS, Immediate Past President of The Heart Rhythm Society; Director of Cardiac Arrhythmia Service, Johns Hopkins Hospital; and Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, MD

 

 

 

Disclosures:
Daiichi Sankyo has provided financial support to the Heart Rhythm Society for conducting this survey. Dr. Calkins consults on behalf of Daiichi Sankyo.

Article PDF
Publications
Sections
Article PDF
Article PDF

A supplement to Cardiology News. This supplement was sponsored by Daiichi Sankyo Inc.

The prevalence of atrial fibrillation (AF) is growing worldwide, and it’s vital for the medical community to better understand the disease and those affected. Daiichi Sankyo sponsored a global survey that was conducted in partnership with the Heart Rhythm Society. The global survey of cardiologists illuminates several important considerations regarding the care and management of patients with non-valvular atrial fibrillation (NVAF).

Faculty:
Hugh Calkins, MD, FHRS, Immediate Past President of The Heart Rhythm Society; Director of Cardiac Arrhythmia Service, Johns Hopkins Hospital; and Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, MD

 

 

 

Disclosures:
Daiichi Sankyo has provided financial support to the Heart Rhythm Society for conducting this survey. Dr. Calkins consults on behalf of Daiichi Sankyo.

A supplement to Cardiology News. This supplement was sponsored by Daiichi Sankyo Inc.

The prevalence of atrial fibrillation (AF) is growing worldwide, and it’s vital for the medical community to better understand the disease and those affected. Daiichi Sankyo sponsored a global survey that was conducted in partnership with the Heart Rhythm Society. The global survey of cardiologists illuminates several important considerations regarding the care and management of patients with non-valvular atrial fibrillation (NVAF).

Faculty:
Hugh Calkins, MD, FHRS, Immediate Past President of The Heart Rhythm Society; Director of Cardiac Arrhythmia Service, Johns Hopkins Hospital; and Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, MD

 

 

 

Disclosures:
Daiichi Sankyo has provided financial support to the Heart Rhythm Society for conducting this survey. Dr. Calkins consults on behalf of Daiichi Sankyo.

Publications
Publications
Article Type
Display Headline
Understanding U.S. Cardiologists’ Perspectives on Non-Valvular Atrial Fibrillation (NVAF)
Display Headline
Understanding U.S. Cardiologists’ Perspectives on Non-Valvular Atrial Fibrillation (NVAF)
Sections
Disallow All Ads
Alternative CME
Disqus Comments
Off
Use ProPublica
Article PDF Media

Highlights in Epilepsy News

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Highlights in Epilepsy News

This supplement highlights recent clinical research news in epilepsy culled from national medical conferences.
 
Click here to download the PDF.

Author and Disclosure Information

 

 

Issue
Neurology Reviews - 22(11)
Publications
Page Number
1-12
Legacy Keywords
ALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-RALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-R
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

This supplement highlights recent clinical research news in epilepsy culled from national medical conferences.
 
Click here to download the PDF.

This supplement highlights recent clinical research news in epilepsy culled from national medical conferences.
 
Click here to download the PDF.

Issue
Neurology Reviews - 22(11)
Issue
Neurology Reviews - 22(11)
Page Number
1-12
Page Number
1-12
Publications
Publications
Article Type
Display Headline
Highlights in Epilepsy News
Display Headline
Highlights in Epilepsy News
Legacy Keywords
ALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-RALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-R
Legacy Keywords
ALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-RALS, Neurology Reviews, Biogen Idec, Richard Bedlack, functional assessment, ALSFSR-R
Sections
Citation Override
2014;22(11)(suppl):1-12
Disallow All Ads
Alternative CME
Use ProPublica

Practical Considerations for Infant Formula Recommendations

Article Type
Changed
Fri, 06/03/2022 - 11:34
Display Headline
Practical Considerations for Infant Formula Recommendations

This educational supplement to Pediatric News was sponsored by Perrigo Nutritionals.

Topics

 

  • Introduction
  • Switching Infant Formula
  • Conclusion

Faculty/Faculty Disclosures

Jenifer R. Lightdale, MD, MPH
Division Chief, Pediatric Gastroenterology,
Hepatology and Nutrition
UMass Memorial Children’s Medical Center
Professor of Pediatrics
University of Massachusetts Medical School
Worcester, MA

Dr. Lightdale reports that she is on the medical advisory board for Perrigo Company plc, and is an invited speaker for Mead Johnson & Company, LLC.

Publications
Sections

This educational supplement to Pediatric News was sponsored by Perrigo Nutritionals.

Topics

 

  • Introduction
  • Switching Infant Formula
  • Conclusion

Faculty/Faculty Disclosures

Jenifer R. Lightdale, MD, MPH
Division Chief, Pediatric Gastroenterology,
Hepatology and Nutrition
UMass Memorial Children’s Medical Center
Professor of Pediatrics
University of Massachusetts Medical School
Worcester, MA

Dr. Lightdale reports that she is on the medical advisory board for Perrigo Company plc, and is an invited speaker for Mead Johnson & Company, LLC.

This educational supplement to Pediatric News was sponsored by Perrigo Nutritionals.

Topics

 

  • Introduction
  • Switching Infant Formula
  • Conclusion

Faculty/Faculty Disclosures

Jenifer R. Lightdale, MD, MPH
Division Chief, Pediatric Gastroenterology,
Hepatology and Nutrition
UMass Memorial Children’s Medical Center
Professor of Pediatrics
University of Massachusetts Medical School
Worcester, MA

Dr. Lightdale reports that she is on the medical advisory board for Perrigo Company plc, and is an invited speaker for Mead Johnson & Company, LLC.

Publications
Publications
Article Type
Display Headline
Practical Considerations for Infant Formula Recommendations
Display Headline
Practical Considerations for Infant Formula Recommendations
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article

Best Practices in IVF Nursing: The IVF nurse—An untapped resource for recruiting and retaining patients

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Best Practices in IVF Nursing: The IVF nurse—An untapped resource for recruiting and retaining patients

Click here to download the PDF.

In vitro fertilization (IVF) nurses play a vital role in caring for fertility patients. Predictably, as the complexity of assisted reproductive technology (ART) services has increased, so has the IVF nurse’s scope of practice and educational requirements.

Their multidimensional responsibilities depend on the knowledge and integration of various fields, including endocrinology, gynecology, obstetrics, embryology, genetics, ethics, psychology, research, information technology, urology, and oncology.

But how do IVF nurses gain a command of so many specialty areas?

Sponsor
This supplement is sponsored by Actavis Inc.
Article PDF
Author and Disclosure Information

Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Marcia Hilse, RNC, MSN,is a Clinical Education Coordinator at Fertility Centers of Illinois, Glenview, IL.
Ms Hilse discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Publications
Legacy Keywords
The First and Only Prescription Non-hormonal Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause
Sections
Author and Disclosure Information

Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Marcia Hilse, RNC, MSN,is a Clinical Education Coordinator at Fertility Centers of Illinois, Glenview, IL.
Ms Hilse discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Author and Disclosure Information

Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Marcia Hilse, RNC, MSN,is a Clinical Education Coordinator at Fertility Centers of Illinois, Glenview, IL.
Ms Hilse discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.

Article PDF
Article PDF
Related Articles
Sponsor
This supplement is sponsored by Actavis Inc.
Sponsor
This supplement is sponsored by Actavis Inc.

Click here to download the PDF.

In vitro fertilization (IVF) nurses play a vital role in caring for fertility patients. Predictably, as the complexity of assisted reproductive technology (ART) services has increased, so has the IVF nurse’s scope of practice and educational requirements.

Their multidimensional responsibilities depend on the knowledge and integration of various fields, including endocrinology, gynecology, obstetrics, embryology, genetics, ethics, psychology, research, information technology, urology, and oncology.

But how do IVF nurses gain a command of so many specialty areas?

Click here to download the PDF.

In vitro fertilization (IVF) nurses play a vital role in caring for fertility patients. Predictably, as the complexity of assisted reproductive technology (ART) services has increased, so has the IVF nurse’s scope of practice and educational requirements.

Their multidimensional responsibilities depend on the knowledge and integration of various fields, including endocrinology, gynecology, obstetrics, embryology, genetics, ethics, psychology, research, information technology, urology, and oncology.

But how do IVF nurses gain a command of so many specialty areas?

Publications
Publications
Article Type
Display Headline
Best Practices in IVF Nursing: The IVF nurse—An untapped resource for recruiting and retaining patients
Display Headline
Best Practices in IVF Nursing: The IVF nurse—An untapped resource for recruiting and retaining patients
Legacy Keywords
The First and Only Prescription Non-hormonal Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause
Legacy Keywords
The First and Only Prescription Non-hormonal Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Abstracts Presented at the 2014 AVAHO Annual Meeting

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Abstracts Presented at the 2014 AVAHO Annual Meeting
Publications
Topics
Sections
Publications
Publications
Topics
Article Type
Display Headline
Abstracts Presented at the 2014 AVAHO Annual Meeting
Display Headline
Abstracts Presented at the 2014 AVAHO Annual Meeting
Sections
Disallow All Ads

Incorporating hereditary cancer syndrome screening into daily practice

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Incorporating hereditary cancer syndrome screening into daily practice

Click here to download the PDF.

Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL

Dr. Snow reports that she is a consultant and speaker for Myriad Genetics Laboratories.

As gynecologists, every day we face an increasing number of clinical issues to consider when seeing our patients. While we strive for comprehensiveness, it is important to stratify our patient care to prioritize life-threatening risk factors. Identifying a pathogenic (deleterious) hereditary cancer gene mutation allows the clinician to implement life-saving, preventive management to reduce cancer risk and improve early cancer detection. Knowing a patient’s hereditary and familial cancer risk will drive gynecologic management and decision making. Without knowing a patient’s personal and/or family history of cancer, the clinician would be unable to determine appropriate treatment options for even the simplest gynecologic issue. Therefore, for every patient at every visit, it is imperative to systematically screen for personal and family risk of cancer and to test appropriate individuals for hereditary cancer syndromes.

The following cases illustrate how knowing a patient’s hereditary cancer risk can affect the care we provide.

CASE 1: Managing fibroids—and cancer risk—in a patient with BRCA1 mutation

YH is a 40-year-old patient, G0P0, who presented for a second opinion regarding large uterine fibroids. Her previous gynecologist treated the fibroids conservatively with medication and a dilation and curettage (D&C) procedure. The patient’s menorrhagia became severe, however, leading to anemia. A hysterectomy was recommended, but the patient wanted a second opinion to discuss options for preserving her uterus.

Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.
Article PDF
Publications
Legacy Keywords
Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL
Sections
Article PDF
Article PDF
Related Articles
Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.
Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.

Click here to download the PDF.

Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL

Dr. Snow reports that she is a consultant and speaker for Myriad Genetics Laboratories.

As gynecologists, every day we face an increasing number of clinical issues to consider when seeing our patients. While we strive for comprehensiveness, it is important to stratify our patient care to prioritize life-threatening risk factors. Identifying a pathogenic (deleterious) hereditary cancer gene mutation allows the clinician to implement life-saving, preventive management to reduce cancer risk and improve early cancer detection. Knowing a patient’s hereditary and familial cancer risk will drive gynecologic management and decision making. Without knowing a patient’s personal and/or family history of cancer, the clinician would be unable to determine appropriate treatment options for even the simplest gynecologic issue. Therefore, for every patient at every visit, it is imperative to systematically screen for personal and family risk of cancer and to test appropriate individuals for hereditary cancer syndromes.

The following cases illustrate how knowing a patient’s hereditary cancer risk can affect the care we provide.

CASE 1: Managing fibroids—and cancer risk—in a patient with BRCA1 mutation

YH is a 40-year-old patient, G0P0, who presented for a second opinion regarding large uterine fibroids. Her previous gynecologist treated the fibroids conservatively with medication and a dilation and curettage (D&C) procedure. The patient’s menorrhagia became severe, however, leading to anemia. A hysterectomy was recommended, but the patient wanted a second opinion to discuss options for preserving her uterus.

Click here to download the PDF.

Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL

Dr. Snow reports that she is a consultant and speaker for Myriad Genetics Laboratories.

As gynecologists, every day we face an increasing number of clinical issues to consider when seeing our patients. While we strive for comprehensiveness, it is important to stratify our patient care to prioritize life-threatening risk factors. Identifying a pathogenic (deleterious) hereditary cancer gene mutation allows the clinician to implement life-saving, preventive management to reduce cancer risk and improve early cancer detection. Knowing a patient’s hereditary and familial cancer risk will drive gynecologic management and decision making. Without knowing a patient’s personal and/or family history of cancer, the clinician would be unable to determine appropriate treatment options for even the simplest gynecologic issue. Therefore, for every patient at every visit, it is imperative to systematically screen for personal and family risk of cancer and to test appropriate individuals for hereditary cancer syndromes.

The following cases illustrate how knowing a patient’s hereditary cancer risk can affect the care we provide.

CASE 1: Managing fibroids—and cancer risk—in a patient with BRCA1 mutation

YH is a 40-year-old patient, G0P0, who presented for a second opinion regarding large uterine fibroids. Her previous gynecologist treated the fibroids conservatively with medication and a dilation and curettage (D&C) procedure. The patient’s menorrhagia became severe, however, leading to anemia. A hysterectomy was recommended, but the patient wanted a second opinion to discuss options for preserving her uterus.

Publications
Publications
Article Type
Display Headline
Incorporating hereditary cancer syndrome screening into daily practice
Display Headline
Incorporating hereditary cancer syndrome screening into daily practice
Legacy Keywords
Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL
Legacy Keywords
Shari Goldman Snow, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Northwestern University
Feinberg School of Medicine
Chicago, IL
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Finding the Best Approach to Autoimmune Connective Tissue Disease Diagnosis

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Finding the Best Approach to Autoimmune Connective Tissue Disease Diagnosis

This educational supplement to Rheumatology News was sponsored by Exagen Diagnostics, Inc.

Jenny Cabas-Vargas, MD
Rheumatologist
Institute for Rheumatic and Autoimmune Diseases
Overlook Medical Center
Summit, New Jersey

Puja Chitkara, MD
Rheumatologist
Center for Arthritis and Rheumatologic Excellence (CARE)
San Diego, California

Stratos Christianakis, MD
Rheumatologist
Assistant Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, California

Chaim Putterman, MD
Professor of Medicine
(Rheumatology) and Microbiology & Immunology
Chief, Division of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

 


Part 1

 


Part 2

 


Part 3

 


Part 4

 


Part 5

 


Part 6

 


Part 7

 


Part 8

 

 

These videos are based on current knowledge and are for educational purposes only. Patients should consult their healthcare providers regarding specific recommendations for diagnosis and treatment.
Publications
Sections

This educational supplement to Rheumatology News was sponsored by Exagen Diagnostics, Inc.

Jenny Cabas-Vargas, MD
Rheumatologist
Institute for Rheumatic and Autoimmune Diseases
Overlook Medical Center
Summit, New Jersey

Puja Chitkara, MD
Rheumatologist
Center for Arthritis and Rheumatologic Excellence (CARE)
San Diego, California

Stratos Christianakis, MD
Rheumatologist
Assistant Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, California

Chaim Putterman, MD
Professor of Medicine
(Rheumatology) and Microbiology & Immunology
Chief, Division of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

 


Part 1

 


Part 2

 


Part 3

 


Part 4

 


Part 5

 


Part 6

 


Part 7

 


Part 8

 

 

These videos are based on current knowledge and are for educational purposes only. Patients should consult their healthcare providers regarding specific recommendations for diagnosis and treatment.

This educational supplement to Rheumatology News was sponsored by Exagen Diagnostics, Inc.

Jenny Cabas-Vargas, MD
Rheumatologist
Institute for Rheumatic and Autoimmune Diseases
Overlook Medical Center
Summit, New Jersey

Puja Chitkara, MD
Rheumatologist
Center for Arthritis and Rheumatologic Excellence (CARE)
San Diego, California

Stratos Christianakis, MD
Rheumatologist
Assistant Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, California

Chaim Putterman, MD
Professor of Medicine
(Rheumatology) and Microbiology & Immunology
Chief, Division of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

 


Part 1

 


Part 2

 


Part 3

 


Part 4

 


Part 5

 


Part 6

 


Part 7

 


Part 8

 

 

These videos are based on current knowledge and are for educational purposes only. Patients should consult their healthcare providers regarding specific recommendations for diagnosis and treatment.
Publications
Publications
Article Type
Display Headline
Finding the Best Approach to Autoimmune Connective Tissue Disease Diagnosis
Display Headline
Finding the Best Approach to Autoimmune Connective Tissue Disease Diagnosis
Sections
Disallow All Ads